Research
Molecular
GLP-1 medicines may suppress tumorigenesis through various mechanisms.
Further research is needed to understand the mechanisms by which GLP-1 medicines may affect tumorigenesis.
StrongQualifiesmedium confidence
GLP-1 medicines acting through weight loss-dependent and weight loss-independent mechanisms hold potential for suppression of tumorigenesis.
Why this rating
The claim is based on data from preclinical cancer models.
Source
Glucagon-like peptide-1 medicines and cancer
Julian M. Yabut et al. · Nature Cancer · 2026
otherCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →